We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR ...

Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

The facility, backed by UVA, CvilleBioHub and a $4.3 million GO Virginia award, will bring lab breakthroughs to health care.

The Birmingham Biotechnology Hub will receive funding to use artificial intelligence to shorten drug development to provide ...

The industry continues to face financial and regulatory headwinds, including high interest rates and uncertainty about ...